Endothelial/Mesenchymal Stem Cell Crosstalk Within Bioprinted Cocultures.


Journal

Tissue engineering. Part A
ISSN: 1937-335X
Titre abrégé: Tissue Eng Part A
Pays: United States
ID NLM: 101466659

Informations de publication

Date de publication:
03 2020
Historique:
pubmed: 29 9 2019
medline: 23 9 2021
entrez: 28 9 2019
Statut: ppublish

Résumé

The development of viable tissue surrogates requires a vascular network that sustains cell metabolism and tissue development. The coculture of endothelial cells (ECs) and mesenchymal stem cells (MSCs), the two key players involved in blood vessel formation, has been heralded in tissue engineering (TE) as one of the most promising approaches for scaffold vascularization. However, MSCs may exert both proangiogenic and antiangiogenic role. Furthermore, it is unclear which cell type is responsible for the upregulation of angiogenic pathways observed in EC:MSC cocultures. There is disagreement on the proangiogenic action of MSCs, as they have also been shown to negatively affect the formation of capillary networks. To address these issues, we investigated the regulation of key angiogenic pathways in scaffolds hosting different EC:MSC ratios fabricated through extrusion-based bioprinting. Human ECs were cocultured with either rat or human MSCs, and the regulation of fundamental angiogenic and arteriogenic pathways was analyzed through DNA, gene, and protein expression. The use of a hybrid human/rat coculture system facilitated pinpointing each cell type role in the regulation of specific genes and showed that MSCs exert a dose-dependent inhibitory effect on the EC expression of angiogenic factors within the first 24 h. Within a week of coculture, MSCs exert a proangiogenic effect, as corroborated in human/human bioprinted cocultures. Interestingly, juxtacrine signaling promoted secretion of the angiogenic factor vascular endothelial growth factor in direct cocultures (EC and MSC co-encapsulated), while paracrine signaling encouraged secretion of the arteriogenic factor platelet-derived growth factor in indirect cocultures (adjacent bioprinting of EC-laden and MSC-laden scaffolds). Overall, the use of a bioprinted system to elucidate EC:MSC interplay allows rapid leveraging of the data for novel vascular TE applications. Despite the transitory negative effect early in the culture, MSC presence is necessary for the regulation of pathways involved in arteriogenesis. With further validation

Identifiants

pubmed: 31559923
doi: 10.1089/ten.TEA.2019.0175
pmc: PMC8851226
doi:

Substances chimiques

Vascular Endothelial Growth Factor A 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Retracted Publication

Langues

eng

Sous-ensembles de citation

IM

Pagination

339-349

Subventions

Organisme : NIBIB NIH HHS
ID : P41 EB023833
Pays : United States

Commentaires et corrections

Type : RetractionIn

Références

J R Soc Interface. 2014 Jan 15;11(92):20131124
pubmed: 24430128
Stem Cells Dev. 2011 Mar;20(3):391-403
pubmed: 20536359
Pediatr Transplant. 2009 Nov;13(7):892-7
pubmed: 19017287
Adv Healthc Mater. 2017 Aug;6(16):
pubmed: 28524375
Annu Rev Biomed Eng. 2013;15:177-200
pubmed: 23642245
Biomaterials. 2016 Nov;106:58-68
pubmed: 27552316
Sci Transl Med. 2012 Nov 14;4(160):160ps23
pubmed: 23152325
Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):300-11
pubmed: 21396416
Tissue Eng Part A. 2018 Mar;24(5-6):527-535
pubmed: 28726587
J Bone Joint Surg Am. 2004 Jul;86(7):1541-58
pubmed: 15252108
Adv Healthc Mater. 2016 Sep;5(17):2174-81
pubmed: 27383032
Int J Radiat Oncol Biol Phys. 1992;22(3):397-402
pubmed: 1735668
Acta Biomater. 2017 Sep 1;59:317-326
pubmed: 28684336
Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):3179-84
pubmed: 26951646
Integr Biol (Camb). 2014 May;6(5):555-63
pubmed: 24676392
Nat Med. 2000 Apr;6(4):389-95
pubmed: 10742145
Nat Biotechnol. 2016 Mar;34(3):312-9
pubmed: 26878319
PLoS One. 2013 Dec 31;8(12):e84256
pubmed: 24391924
Stem Cells Dev. 2014 Feb 15;23(4):319-32
pubmed: 24171705
J Cell Biol. 2001 Apr 30;153(3):543-53
pubmed: 11331305
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):7968-73
pubmed: 24843171
Biotechnol Bioeng. 2019 Jan;116(1):181-192
pubmed: 30298908
Nature. 2011 May 19;473(7347):298-307
pubmed: 21593862
Adv Funct Mater. 2012 May 23;22(10):2027-2039
pubmed: 22907987
Ann Biomed Eng. 2018 Dec;46(12):1963-1974
pubmed: 30003503
Stem Cells Dev. 2013 Mar 15;22(6):855-65
pubmed: 23072248
Blood. 2009 Apr 30;113(18):4197-205
pubmed: 19036701
Trends Biotechnol. 2016 Sep;34(9):733-745
pubmed: 27032730
Biomaterials. 2012 May;33(15):3824-34
pubmed: 22365811
FASEB J. 2001 Feb;15(2):447-57
pubmed: 11156960
Stem Cells Dev. 2013 Jan 1;22(1):148-57
pubmed: 22734943
Annu Rev Immunol. 2014;32:51-82
pubmed: 24313777
Genes Cancer. 2011 Dec;2(12):1117-33
pubmed: 22866203
Stem Cell Res. 2011 Nov;7(3):186-97
pubmed: 21907162
Biomed Res Int. 2014;2014:320123
pubmed: 24967356

Auteurs

Marco Santoro (M)

Fischell Department of Bioengineering, University of Maryland, College Park, Maryland.
Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland.

Tolulope O Awosika (TO)

Fischell Department of Bioengineering, University of Maryland, College Park, Maryland.
Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland.

Kirstie L Snodderly (KL)

Fischell Department of Bioengineering, University of Maryland, College Park, Maryland.
Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland.

Amelia C Hurley-Novatny (AC)

Fischell Department of Bioengineering, University of Maryland, College Park, Maryland.
Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland.

Max J Lerman (MJ)

Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland.
Department of Materials Science and Engineering, University of Maryland, College Park, Maryland.

John P Fisher (JP)

Fischell Department of Bioengineering, University of Maryland, College Park, Maryland.
Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH